US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 1.160
- -0.060-4.92%
Close Nov 7 16:00 ET
- 1.170
- +0.010+0.86%
Post 16:00 ET
85.31MMarket Cap-6444P/E (TTM)
1.240High1.160Low331.87KVolume1.190Open1.220Pre Close398.64KTurnover0.61%Turnover Ratio12.89P/E (Static)73.54MShares1.90052wk High2.98P/B63.40MFloat Cap0.82152wk Low--Dividend TTM54.65MShs Float1037.500Historical High--Div YieldTTM6.56%Amplitude0.700Historical Low1.201Avg Price1Lot Size
About Protalix Biotherapeutics Company
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Company Profile
SymbolPLX
Company NameProtalix Biotherapeutics
Listing DateApr 9, 1996
Issue Price6.00
Founded1993
CEOMr. Dror Bashan
MarketAMEX
Employees208
Fiscal Year Ends12-31
Address2 University Plaza,Suite 100
CityHackensack
ProvinceNew Jersey
CountryUnited States of America
Zip Code07601
Websitehttp://www.protalix.com
Company Executives
- Name
- Position
- Salary
- Dror Bashan
- Director, President and Chief Executive Officer
- 2.68M
- Eyal Rubin
- Senior Vice President, Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer
- 1.03M
- Yaron Naos
- Senior Vice President, Operations
- 776.37K
- Dr. Eliot Richard Forster, M.B.A.,PhD
- Chairman of the Board
- 47.99K
- Amos Bar Shalev
- Independent Director
- 79.91K
- Gwen A. Melincoff
- Independent Director
- 79.91K
- Dr. Shmuel Ben-Zvi, PhD
- Independent Director
- 74.71K
- Dr. Pol F. Boudes,M.D.
- Independent Director
- 115.39K
- Dr. Aharon Schwartz,PhD
- Independent Director
- 79.91K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data